CORONAVIRUS DIARRHEA (COVID 19) IN CHILDREN

DOI:

https://doi.org/10.54890/.v1i1.230

Abstract

Summary. Clinical and epidemiological characteristics of coronavirus diarrhea in 44 young
children who were treated at the Republican Clinical Infectious Diseases Hospital for the
period 2020-2021. In the age structure of children with coronavirus diarrhea, children over 1
year of age dominated 59.1%, children in the first year of life accounted for 40.9%. Of the
remaining hospitals, 56.8% were children who were diagnosed with an acute intestinal
infection. Coronavirus diarrhea in the examined children in 59.0% was combined with viral-
bacterial pneumonia. The diagnosis of coronavirus infection was confirmed by the detection
of SARS-CoV-2 RNA in swabs from the oropharynx and nasopharynx by polymerase chain
reaction (PCR). Quantitative determination of blood procalcitonin (PCT) was determined in
79.5% of patients with secretory diarrhea. As a result, the test showed that 11 (25.0%) children
had a course of coronavirus infection without bacterial complications. The disease generally
proceeded in a moderate form with a favorable outcome. As a result, it was found that
secretory diarrhea is one of the symptoms of coronavirus infection, and the severity of the
condition of patients with diarrhea is due to the frequent combination of viral-bacterial
pneumonia.

Keywords:

coronavirus, children, PCR diagnostics, procalcitonin, diarrhea, pneumonia, severity.

Author Biographies

M.K. Bedelbaev, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

Z.K. Dzholbunova, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

A.K. Mambetova, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

Е.А. Khalupko, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

А. Akmatov, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

O.S. Bukhantseva , Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Pediatric Infectious Diseases

References

1. Болехан В.Н., Улюкин И.М., Пелешок С.А. Особенности развития эпидемии коронавирусной инфекции COVID-19. Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. 2020;(4):16-26. https://doi.org/10.25016/2541-7487-2020-0-4-16-26

2. Щелканов М.Ю., Попова А.Ю., Дедков В.Г., Акимкин В.Г., Малеев В.В. История изучения и современная классификация коронавирусов (Nidovirales: Coronaviridae). Инфекция и иммунитет. 2020;10(2):221-246. https://doi.org/10.15789/2220-7619-HOI-1412

3. Hui, David S.The continuing epidemic threat of novel coronaviruses to global health – the latest novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020 14 January;91:264-266. https://doi.org/10.1016/j.ijid.2020.01.009.

4. Wang Q.X., Zeng X.H., Zheng S.L. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-n. Cov. Eur. Rev. Med. Pharmaco. Sci. 2020;24(7):3437. https://doi.org/10.26355/ eurrev_202004_20795

5. Talha Burki. The origin of SARS-CoV-2 variants of concern.The Lancet Infectious Diseases. 2022-02- 01; 22(2):174–175. https://doi.org/10.1016/S1473-3099(22)00015-9.

6. Changshuo Wei, Ke-Jia Shan, Weiguang Wang. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. Journal of Genetics and Genomics. 2021-12-01.;48(12):1111–1121. https://doi.org/10.1016/j.jgg.2021.12.00 3.

7. Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination. 2022-01-17;2022.01.13.22269243. https://doi.org/10.1101/2022.01.13.22269243v1

8. Беликова Ю.А., Самсонов Ю.В., Абакушина Е.В. Современные вакцины и коронавирусные инфекции. Research'n Practical Medicine Journal. 2020;7(4):135-154. https://doi.org/10.17709/2409-2231-2020-7-4-11

9. Sifuentes Rodrнguez E, Palacios Reyes D. COVID-19: The outbreak caused by a new coronavirus. Bol. Med. Hosp. Infant. Mex. 2020;77(2):47–53. https://doi.org/10.24875/BMHIM.20000039.

10. Khadija Khan, Farina Karim, Sandile Cele. Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant. 2022-01-28. 2021;12.27.21268439. https://doi.org/10.1101/2021.12.27.21268439v2

11. Мелехина Е.В., Горелов А.В., Музыка А.Д. Клинические особенности течения COVID-19 у детей различных возрастных групп. Вопросы практической педиатрии, 2020;15(2):7–20.

12. Намазова-Баранова Л.С. Коронавирусная инфекция (COVID-19) у детей (состояние на апрель 2020). Педиатрическая фармакология, 2020;17(2):85-93.

13. Lamers M, Beumer J, van der Vaart J. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50–4. https://doi.org/10.1126/science.abc166 9

14. Wang F, Zheng S, Zheng C. Attaching clinical significance to COVID-19-associated diarrhea. Life Sci. 2020; 260:118312. https://doi.org/10.1016/j.lfs.2020.11831 2

Zhou J, Li C, Liu X. Infection of bat and human intestinal organoids by SARS-CoV-2. Nat. Medical. 2020; 26(7):1077–83. https://doi.org/10.1038/s41591-020-0912-6

Published

2022-09-24

How to Cite

Беделбаев, М., З. Джолбунова, А. . Мамбетова, Е. Халупко, А. Акматов, and О. Буханцева. “CORONAVIRUS DIARRHEA (COVID 19) IN CHILDREN ”. Euroasian Health Journal, vol. 1, no. 1, Sept. 2022, pp. 95-102, doi:10.54890/.v1i1.230.

Issue

Section

QUESTIONS OF PEDIATRY